{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T03:45:11Z","timestamp":1766720711383,"version":"3.38.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01CA216815","R01DK140079"],"award-info":[{"award-number":["R01CA216815","R01DK140079"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.apsb.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T18:02:32Z","timestamp":1731002552000},"page":"963-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Induction of Cyp2e1 contributes to asparaginase-induced hepatocyte sensitization to lipotoxicity"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1963-5860","authenticated-orcid":false,"given":"Yin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keito","family":"Hoshitsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-8871","authenticated-orcid":false,"given":"Lauren","family":"Kokai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-7467","authenticated-orcid":false,"given":"Xiaochao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.11.002_bib1","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1517\/14656566.8.12.1977","article-title":"PEG-asparaginase","volume":"8","author":"Fu","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.apsb.2024.11.002_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1634\/theoncologist.12-8-991","article-title":"FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)","volume":"12","author":"Dinndorf","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.apsb.2024.11.002_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12072-019-09971-2","article-title":"Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis","volume":"13","author":"Kamal","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.apsb.2024.11.002_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1097-0142(197002)25:2<253::AID-CNCR2820250204>3.0.CO;2-U","article-title":"Toxicity of E. coli l-asparaginase in man","volume":"25","author":"Oettgen","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.apsb.2024.11.002_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/asheducation-2006.1.128","article-title":"Myths and lessons from the adult\/pediatric interface in acute lymphoblastic leukemia","volume":"2006","author":"Sallan","year":"2006","journal-title":"Hematology"},{"key":"10.1016\/j.apsb.2024.11.002_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cpt.629","article-title":"Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy","volume":"102","author":"Liu","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2024.11.002_bib7","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.apsb.2021.11.022","article-title":"Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in mice","volume":"11","author":"Kumar","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.11.002_bib8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.ijo.0803254","article-title":"Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa\/fa) rats","volume":"30","author":"Raju","year":"2006","journal-title":"Int J Obes"},{"key":"10.1016\/j.apsb.2024.11.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100086","article-title":"Protocol for primary mouse hepatocyte isolation","volume":"1","author":"Charni-Natan","year":"2020","journal-title":"STAR Protoc"},{"key":"10.1016\/j.apsb.2024.11.002_bib10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajpath.2012.08.004","article-title":"Inhibition of NF-\u03baB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease","volume":"181","author":"Dou","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2024.11.002_bib11","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1021\/jf060043k","article-title":"DATS reduces LPS-induced iNOS expression, NO production, oxidative stress, and NF-\u03baB activation in RAW 264.7 macrophages","volume":"54","author":"Liu","year":"2006","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2024.11.002_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.toxlet.2012.08.017","article-title":"Effect of garlic-derived organosulfur compounds on mitochondrial function and integrity in isolated mouse liver mitochondria","volume":"214","author":"Caro","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.apsb.2024.11.002_bib13","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1128\/MCB.01147-13","article-title":"Estrogen sulfotransferase\/SULT1E1 promotes human adipogenesis","volume":"34","author":"Ihunnah","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2024.11.002_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2024.11.002_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and\u00a0dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.apsb.2024.11.002_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.apsb.2024.11.002_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2011.05.002","article-title":"Desnutrin\/ATGL is regulated by AMPK and is required for a brown adipose phenotype","volume":"13","author":"Ahmadian","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2024.11.002_bib18","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1530\/JME-13-0277","article-title":"Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease","volume":"52","author":"Nielsen","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.apsb.2024.11.002_bib19","first-page":"4554","article-title":"l-Asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans","volume":"41","author":"Riccardi","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2024.11.002_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/clpt.2009.162","article-title":"Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia","volume":"86","author":"Panetta","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2024.11.002_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MPH.0b013e318047b79d","article-title":"Clinical pharmacology of asparaginases in the United States: asparaginase population pharmacokinetic and pharmacodynamic (PK\u2013PD) models (NONMEM) in adult and pediatric ALL patients","volume":"29","author":"Avramis","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.apsb.2024.11.002_bib22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphys.2017.00902","article-title":"Palmitic acid: physiological role, metabolism and nutritional implications","volume":"8","author":"Carta","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2024.11.002_bib23","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1194\/jlr.R066597","article-title":"Oxidative stress and lipotoxicity","volume":"57","author":"Hauck","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2024.11.002_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2024.11.002_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/dmd.110.035691","article-title":"Ethanol induction of CYP2A5: permissive role for CYP2E1","volume":"39","author":"Lu","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2024.11.002_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.11.002_bib27","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","article-title":"Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1","volume":"268","author":"Laethem","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.11.002_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/1389200216666150812123554","article-title":"Diallyl sulfide: potential use in novel therapeutic interventions in alcohol, drugs, and disease mediated cellular toxicity by targeting cytochrome P450 2E1","volume":"16","author":"Rao","year":"2015","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.apsb.2024.11.002_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.leu.2400703","article-title":"Transient hyperlipidemia during treatment of ALL with l-asparaginase is related to decreased lipoprotein lipase activity","volume":"11","author":"Hoogerbrugge","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2024.11.002_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28040","article-title":"Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia","volume":"67","author":"Finch","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.apsb.2024.11.002_bib31","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.ejca.2014.06.023","article-title":"Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia","volume":"50","author":"Bhojwani","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.apsb.2024.11.002_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11306-021-01814-2","article-title":"Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepository","volume":"17","author":"Saito","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.apsb.2024.11.002_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1097-0142(197108)28:2<361::AID-CNCR2820280215>3.0.CO;2-3","article-title":"Duration and severity of fatty metamorphosis of the liver following l-asparaginase therapy","volume":"28","author":"Pratt","year":"1971","journal-title":"Cancer"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524004192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524004192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:39:53Z","timestamp":1741693193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524004192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2211383524004192"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.11.002","relation":{},"ISSN":["2211-3835"],"issn-type":[{"type":"print","value":"2211-3835"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of Cyp2e1 contributes to asparaginase-induced hepatocyte sensitization to lipotoxicity","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}